SCHEMBL7488762

SCHEMBL7488762

CNC(=O)CC(C(=O)N(O)CCOc1ccc(Cl)cc1)C(C)C

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 1/20 0.44
▸ MEN1 O00255 5/20 0.44
▸ KMT2A Q03164 5/20 0.44
▸ MMP1 P03956 1/20 0.41
▸ MMP3 P08254 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ BLM P54132 1/20 0.40
▸ PMP22 Q01453 1/20 0.40
▸ ATM Q13315 1/20 0.40
▸ POLB P06746 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ FDPS P14324 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7491428 0.80 HDAC3 (0.40) KMT2ACYP1A2CYP2C19POLBALDH1A1
SCHEMBL7484970 0.72 MEN1 (0.47) HRH3MEN1KMT2ACYP1A2CYP3A4
SCHEMBL7484977 0.72 CASP1 (0.50) MEN1KMT2AATMALDH1A1
SCHEMBL2456964 0.70 HRH3 (0.50) HRH3MEN1KMT2ACYP1A2CYP3A4
SCHEMBL6946483 0.68 MEN1 (0.46) HRH3MEN1KMT2ACYP1A2CYP3A4
SCHEMBL7497814 0.68 CYP1A2 (0.47) HRH3MEN1KMT2ACYP1A2CYP3A4
SCHEMBL7492782 0.68 KMT2A (0.62) MEN1KMT2APOLBMAPTALDH1A1
SCHEMBL7497820 0.67 NPC1 (0.47) MEN1KMT2AATMMAPTALDH1A1
SCHEMBL28417577 0.67 PPARG (0.55) MEN1KMT2ACYP1A2ALDH1A1RAB9A
Hydrochloric Acid SCHEMBL27734857 0.66 KMT2A (0.60) MEN1KMT2APOLBMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6462042-B1 TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME INHIBITORS; INFLAMMATORY DISEASES, AUTOIMMUNE DISEASES, CANCER, CARDIO-VASCULAR DISEASES, RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, OSTEOPOROSIS, NEURODEGENERATION, ALZHEIMER'S DISEASE, STROKE DARWIN DISCOVERY LIMITED (GB) 2002-10-08 — — US claimed
EP-1237867-A1 HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEINASE (MMP) INHIBITORS Darwin Discovery Limited (GB) 2002-09-11 — — EP claimed
WO-2001044188-A1 HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEINASE (MMP) INHIBITORS DARWIN DISCOVERY LIMITED (GB) 2001-06-21 — — WO claimed
US-6462042-B1 TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME INHIBITORS; INFLAMMATORY DISEASES, AUTOIMMUNE DISEASES, CANCER, CARDIO-VASCULAR DISEASES, RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, OSTEOPOROSIS, NEURODEGENERATION, ALZHEIMER'S DISEASE, STROKE DARWIN DISCOVERY LIMITED (GB) 2002-10-08 — — US disclosed
Send feedback